Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation
- 6 October 2003
- Vol. 22 (5-6) , 575-585
- https://doi.org/10.1016/j.vaccine.2003.09.005
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Workshop summaryVaccine, 2002
- Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean childrenThe Pediatric Infectious Disease Journal, 2001
- A TritonX-100-split Virion Influenza Vaccine is Safe and Fulfills the Committee for Proprietary Medicinal Products (CPMP) Recommendations for the European Community for Immunogenicity, in Children, Adults and the ElderlyBiologicals, 2000
- Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccineVaccine, 1999
- Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infectionVaccine, 1995
- Adverse reactions after diphtheria—tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccinationVaccine, 1994
- Postimmunization (Vaccination) Injection-site ReactionsThe American Journal of Surgical Pathology, 1994
- Granulomas Associated with Tetanus Toxoid ImmunizationThe American Journal of Dermatopathology, 1993
- Vaccination granulomas and aluminium allergy: course and prognostic factorsContact Dermatitis, 1992
- Advantages of Aluminium Hydroxide Adsorbed Combined Diphtheria, Tetanus, and Pertussis Vaccines for the Immunization of InfantsBMJ, 1969